Viewing nowGlimeryl Tablets 2 mg (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 200300034 · Notified 2003.12.08 · Insurance code 648503520
Improves blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in conjunction with dietary and exercise therapy. In cases where blood sugar control is insufficient, it may be prescribed in combination with other hypoglycemic agents or insulin. For instance, when sulfonylureas or metformin monotherapy is inadequate, using this medication alongside metformin can enhance blood sugar control. This complex therapeutic approach further improves blood sugar management in patients. This medication is used effectively to strengthen blood sugar control in type 2 diabetes.
Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial Dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered drug. 4) Dose monitoring While taking this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this drug, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is combined with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or who are in a comatose state. Additionally, patients who have had allergic reactions to this medication or its components, as well as sulfonylureas or sulfonamides, should avoid administration. There is no experience in using this medication in patients with severely impaired liver or kidney function, hence a switch to insulin therapy is recommended. It should not be administered to pregnant women or breastfeeding women due to potential harm to the fetus or newborn. In cases of severe infection, pre- or post-surgery, or in severely traumatized patients, insulin treatment is necessary and this medication should not be used. In patients where food absorption is decreased due to diarrhea or vomiting, caution is needed for the risk of hypoglycemia. During the initial dosing, there is a high risk of hypoglycemia, so blood sugar levels need to be closely monitored, especially in elderly patients, those with poor nutritional status or irregular meals, and those with imbalanced exercise and meal intake. Caution is also necessary for those who consume alcohol, have impaired kidney and liver function, or are taking multiple medications, as the risk of hypoglycemia may increase. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness; in severe cases, seizures or coma may occur, requiring immediate treatment. Various side effects such as blurred vision, dyspepsia, liver dysfunction, blood abnormalities, and allergic reactions may occur, hence any unusual symptoms should be reported to a doctor or pharmacist promptly. This medication should be taken regularly alongside dietary and exercise therapies, and should immediate sugar intake be required during a hypoglycemic episode.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or energy, depression, confusion, speech disturbances, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the drug's efficacy and safety over time.
Green rectangular tablets
Domestic use - 100 tablets/bottle, Domestic use - 30 tablets/bottle, Export use - 100 tablets/box [(10 tablets/PTP × 10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.